Stay updated with breaking news from Deep Pharma Intelligence. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Major pharmaceutical companies are increasingly turning to artificial intelligence (AI) to revolutionize drug development processes
During the last nine years, the cumulative amount of AI investments across the pharma and biotech sectors has increased by almost thirtyfold, to $24.6 billion as of last December.
Unveiling the Global State of AI in Cancer VaccinesNew Industry Report & IT-Platform Provide In-Depth Analysis of AI in Pharma17 August 2023AI in Cancer Vaccines 2023 MindmapAugust 17, 2023 - London, UK: Deep Pharma Intelligence, a leading BioTech market research agency focused on sophisticated analytics, benchm...
17 August 2023AI in Oncology 2023 Mindmap August 17, 2023 - London, UK: Deep Pharma Intelligence, a leading BioTech market research agency focused on sophisticated analytics, benchmarking and forecasting of emerging and frontier domains in the Pharmaceutical, BioTech and Healthcare industries, today annou...
40% of Global AI Companies Focus on Early Drug Development while AI-Powered Startups Reshape the Future of Drug DiscoveryNew industry report from Deep Pharma Intelligence has redefined the Global State of AI in Drug DiscoveryAugust 16, 2023 - London, UK: The largest profiling of the global AI in the Drug Discovery i...